HLA-DRB1 and rheumatoid arthritis: In genetically predisposed individuals, particularly those carrying HLA-DRB1 shared epitope alleles, the immunologic response to EBV is believed to be skewed toward a pathogenic, pro-inflammatory phenotype, increasing the likelihood of both RA onset and EBV-driven lymphoproliferative transformation [13,14].